Method of treating fulminant hepatic failure using DLL4 cytokine
AssigneeZhejiang University
InventorsJun Li, Lanjuan Li, Xin Chen, Jiang Li
Life of this patent
Estimating the term…
Abstract
A method of treating fulminant hepatic failure in a subject, includes administering a therapeutically effective amount of a pharmaceutical composition to the subject, wherein the pharmaceutical composition comprises a DLL4 cytokine. A method of treating liver failure, sub-acute liver failure, chronic liver failure or acute-on-chronic liver failure in a subject, includes administering an therapeutically effective amount of a DLL4 cytokine to the subject.
Claims6
A method of treating liver failure in a subject, comprising administering a therapeutically effective amount of a pharmaceutical composition to the subject, wherein the pharmaceutical composition comprises a human delta like ligand 4 (DLL4) cytokine as set forth in SEQ ID NO:
- 1.
Dependencies are inferred from the claim text.